Patents by Inventor Anil Kumar Vuppala

Anil Kumar Vuppala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11227378
    Abstract: A system for generating training datasets is provided. The system uses base images to generate a large number of images that include non-defective and defective characteristics. The generated images are then used to train a model that may be used to predict defects in real world images of a manufacturing process.
    Type: Grant
    Filed: November 13, 2019
    Date of Patent: January 18, 2022
    Assignee: SOFTWARE AG
    Inventors: Rainer Burkhardt, Anil Kumar Vuppala, Tridivesh Jena
  • Publication number: 20210142467
    Abstract: A system for generating training datasets is provided. The system uses base images to generate a large number of images that include non-defective and defective characteristics. The generated images are then used to train a model that may be used to predict defects in real world images of a manufacturing process.
    Type: Application
    Filed: November 13, 2019
    Publication date: May 13, 2021
    Inventors: Rainer BURKHARDT, Anil Kumar VUPPALA, Tridivesh JENA
  • Publication number: 20140200225
    Abstract: A compound of formula (I) wherein R1 to R15, P1, P2, A, B and Q are as defined in the claims and pharmaceutically acceptable salts and esters thereof, are disclosed. The compounds of formula (I) possess utility as matriptase inhibitors and are useful in the treatment of matriptase dependent conditions, particularly cancer.
    Type: Application
    Filed: March 27, 2014
    Publication date: July 17, 2014
    Applicant: ORION CORPORATION
    Inventors: Rajeev GOSWAMI, Anil Kumar VUPPALA, Ramesh VELUDANDI, Ramesh SISTLA, Chakshusmathi GHADIYARAM, Muralidhara RAMACHANDRA
  • Patent number: 8722930
    Abstract: A compound of formula (I) wherein R1 to R15, P1, P2, A, B and Q are as defined in the claims and pharmaceutically acceptable salts and esters thereof, are disclosed. The compounds of formula (I) possess utility as matriptase inhibitors and are useful in the treatment of matriptase dependent conditions, particularly cancer.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: May 13, 2014
    Assignee: Orion Corporation
    Inventors: Rajeev Goswami, Anil Kumar Vuppala, Ramesh Veludandi, Ramesh Sistla, Chakshusmathi Ghadiyaram, Muralidhara Ramachandra
  • Publication number: 20120136002
    Abstract: A compound of formula (I) wherein R1 to R15, P1, P2, A, B and Q are as defined in the claims and pharmaceutically acceptable salts and esters thereof, are disclosed. The compounds of formula (I) possess utility as matriptase inhibitors and are useful in the treatment of matriptase dependent conditions, particularly cancer.
    Type: Application
    Filed: May 18, 2010
    Publication date: May 31, 2012
    Inventors: Rajeev Goswami, Anil Kumar Vuppala, Ramesh Veludandi, Ramesh Sistla, Chakshusmathi Ghadiyaram, Muralidhara Ramachandra